Clinical and Experimental Hepatology

 
3/2026 vol. 12
Recommendations for treatment of hepatitis C in 2026 from the Polish Group of Experts for HCV

Review paper

Clin Exp HEPATOL 2026; 12, 3: 191–199

DOI: https://doi.org/10.5114/ceh.2026.164531
Abstract View text
Management of HCV-infected patients after successful direct-acting antiviral therapy

Review paper

Clin Exp HEPATOL 2026; 12, 3: 200-208

DOI: https://doi.org/10.5114/ceh.2026.161809
Abstract View text
Liver abnormalities in patients with inflammatory bowel disease: a practical review

Review paper

Clin Exp HEPATOL 2026; 12, 3: 214–225

DOI: https://doi.org/10.5114/ceh.2026.164941
Abstract View text
Dietary interventions in metabolic dysfunction-associated steatotic liver disease: current evidence, research priorities, and clinical translation

Review paper

Clin Exp HEPATOL 2026; 12, 3: 226–241

DOI: https://doi.org/10.5114/ceh.2026.164368
Abstract View text
Initial clinical outcomes of laparoscopic hepatectomy in patients with hepatocellular carcinoma

Original paper

Clin Exp HEPATOL 2026; 12, 3: 242–248

DOI: https://doi.org/10.5114/ceh.2026.164158
Abstract View text
Characteristics of patients with HIV/HBV coinfection who were diagnosed with HDV infection

Original paper

Clin Exp HEPATOL 2026; 12, 3: 259–267

DOI: https://doi.org/10.5114/ceh.2026.164153
Abstract View text
HIV and HCV testing strategies in the emergency department setting

Original paper

Clin Exp HEPATOL 2026; 12, 3: 268–275

DOI: https://doi.org/10.5114/ceh.2026.164369
Abstract View text
Long-term efficacy and safety of switching from entecavir to tenofovir alafenamide

Original paper

Clin Exp HEPATOL 2026; 12, 3: 276–283

DOI: https://doi.org/10.5114/ceh.2026.164768
Abstract View text
Association between the triglyceride-glucose index and fatty liver among healthcare professionals

Original paper

Clin Exp HEPATOL 2026; 12, 3: 298–304

DOI: https://doi.org/10.5114/ceh.2026.164258
Abstract View text